ORIX - SPONSORED ADR (IX) Fundamental Analysis & Valuation

NYSE:IX • US6863301015

Current stock price

29.16 USD
-0.11 (-0.38%)
At close:
29.16 USD
0 (0%)
After Hours:

This IX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. IX Profitability Analysis

1.1 Basic Checks

  • In the past year IX was profitable.
  • In the past year IX had a positive cash flow from operations.
  • Each year in the past 5 years IX has been profitable.
  • IX had a positive operating cash flow in each of the past 5 years.
IX Yearly Net Income VS EBIT VS OCF VS FCFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T

1.2 Ratios

  • The Return On Assets of IX (2.50%) is better than 63.00% of its industry peers.
  • IX's Return On Equity of 9.90% is in line compared to the rest of the industry. IX outperforms 58.00% of its industry peers.
  • IX has a Return On Invested Capital (3.15%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for IX is significantly below the industry average of 8.06%.
  • The last Return On Invested Capital (3.15%) for IX is above the 3 year average (2.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROIC 3.15%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
IX Yearly ROA, ROE, ROICIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of IX (14.49%) is comparable to the rest of the industry.
  • IX's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 19.97%, IX is doing good in the industry, outperforming 69.00% of the companies in the same industry.
  • IX's Operating Margin has been stable in the last couple of years.
  • IX has a better Gross Margin (42.41%) than 64.00% of its industry peers.
  • IX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
IX Yearly Profit, Operating, Gross MarginsIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. IX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IX is destroying value.
  • The number of shares outstanding for IX has been reduced compared to 1 year ago.
  • The number of shares outstanding for IX has been reduced compared to 5 years ago.
  • IX has a better debt/assets ratio than last year.
IX Yearly Shares OutstandingIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IX Yearly Total Debt VS Total AssetsIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T

2.2 Solvency

  • Based on the Altman-Z score of 0.65, we must say that IX is in the distress zone and has some risk of bankruptcy.
  • IX has a Altman-Z score (0.65) which is comparable to the rest of the industry.
  • IX has a debt to FCF ratio of 3051.64. This is a negative value and a sign of low solvency as IX would need 3051.64 years to pay back of all of its debts.
  • IX has a worse Debt to FCF ratio (3051.64) than 62.00% of its industry peers.
  • IX has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
  • IX has a Debt to Equity ratio of 1.47. This is in the lower half of the industry: IX underperforms 63.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Altman-Z 0.65
ROIC/WACC0.86
WACC3.68%
IX Yearly LT Debt VS Equity VS FCFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

2.3 Liquidity

  • A Current Ratio of 0.48 indicates that IX may have some problems paying its short term obligations.
  • IX has a worse Current ratio (0.48) than 60.00% of its industry peers.
  • A Quick Ratio of 0.43 indicates that IX may have some problems paying its short term obligations.
  • IX's Quick ratio of 0.43 is on the low side compared to the rest of the industry. IX is outperformed by 61.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.43
IX Yearly Current Assets VS Current LiabilitesIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500B 1T 1.5T 2T 2.5T

3

3. IX Growth Analysis

3.1 Past

  • IX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.80%.
  • IX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.09% yearly.
  • IX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.76%.
  • Measured over the past years, IX shows a decrease in Revenue. The Revenue has been decreasing by -1.43% on average per year.
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%

3.2 Future

  • Based on estimates for the next years, IX will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.43% on average per year.
  • IX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.36% yearly.
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y20.94%
EPS Next 5Y15.43%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y6.77%
Revenue Next 5Y6.36%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IX Yearly Revenue VS EstimatesIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1T 2T 3T
IX Yearly EPS VS EstimatesIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100 200 300 400

4

4. IX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.84, which indicates a rather expensive current valuation of IX.
  • Compared to the rest of the industry, the Price/Earnings ratio of IX is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 24.75, IX is valued at the same level.
  • The Price/Forward Earnings ratio is 13.40, which indicates a correct valuation of IX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IX is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. IX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.84
Fwd PE 13.4
IX Price Earnings VS Forward Price EarningsIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • IX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IX is cheaper than 68.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IX indicates a slightly more expensive valuation: IX is more expensive than 62.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2396.27
EV/EBITDA 9.6
IX Per share dataIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as IX's earnings are expected to grow with 20.94% in the coming years.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y21.71%
EPS Next 3Y20.94%

7

5. IX Dividend Analysis

5.1 Amount

  • IX has a Yearly Dividend Yield of 3.21%.
  • IX's Dividend Yield is a higher than the industry average which is at 2.13.
  • Compared to an average S&P500 Dividend Yield of 1.89, IX pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.21%

5.2 History

  • On average, the dividend of IX grows each year by 7.63%, which is quite nice.
  • IX has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of IX decreased in the last 3 years.
Dividend Growth(5Y)7.63%
Div Incr Years2
Div Non Decr Years2
IX Yearly Dividends per shareIX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

  • 31.18% of the earnings are spent on dividend by IX. This is a low number and sustainable payout ratio.
  • IX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.18%
EPS Next 2Y21.71%
EPS Next 3Y20.94%
IX Yearly Income VS Free CF VS DividendIX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B -200B -400B
IX Dividend Payout.IX Dividend Payout, showing the Payout Ratio.IX Dividend Payout.PayoutRetained Earnings

IX Fundamentals: All Metrics, Ratios and Statistics

ORIX - SPONSORED ADR

NYSE:IX (3/30/2026, 8:10:13 PM)

After market: 29.16 0 (0%)

29.16

-0.11 (-0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-11
Inst Owners48.91%
Inst Owner Change4.56%
Ins OwnersN/A
Ins Owner Change0%
Market Cap32.02B
Revenue(TTM)3.13T
Net Income(TTM)439.75B
Analysts77.5
Price Target32.61 (11.83%)
Short Float %0.07%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield 3.21%
Yearly Dividend0.75
Dividend Growth(5Y)7.63%
DP31.18%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.8%
PT rev (3m)9.45%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.49%
EPS NY rev (3m)2.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.11%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 19.84
Fwd PE 13.4
P/S 1.69
P/FCF 2396.27
P/OCF 3.91
P/B 1.15
P/tB 1.65
EV/EBITDA 9.6
EPS(TTM)1.47
EY5.04%
EPS(NY)2.18
Fwd EY7.46%
FCF(TTM)0.01
FCFY0.04%
OCF(TTM)7.45
OCFY25.55%
SpS17.29
BVpS25.29
TBVpS17.69
PEG (NY)0.78
PEG (5Y)N/A
Graham Number28.92
Profitability
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROCE 4.53%
ROIC 3.15%
ROICexc 3.5%
ROICexgc 4.93%
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
FCFM 0.07%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
ROICexc(3y)2.88%
ROICexc(5y)2.73%
ROICexgc(3y)3.79%
ROICexgc(5y)3.66%
ROCE(3y)3.76%
ROCE(5y)3.56%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y0.16%
ROICexc growth 3Y1.76%
ROICexc growth 5Y0.31%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Debt/EBITDA 6.49
Cap/Depr 327.15%
Cap/Sales 43.02%
Interest Coverage 250
Cash Conversion 130.12%
Profit Quality 0.49%
Current Ratio 0.48
Quick Ratio 0.43
Altman-Z 0.65
F-Score7
WACC3.68%
ROIC/WACC0.86
Cap/Depr(3y)325.04%
Cap/Depr(5y)298.28%
Cap/Sales(3y)43.48%
Cap/Sales(5y)39.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y20.94%
EPS Next 5Y15.43%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y6.77%
Revenue Next 5Y6.36%
EBIT growth 1Y1.57%
EBIT growth 3Y7.89%
EBIT growth 5Y6.16%
EBIT Next Year12822.9%
EBIT Next 3Y454.92%
EBIT Next 5YN/A
FCF growth 1Y111.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.39%
OCF growth 3Y5.62%
OCF growth 5Y4.52%

ORIX - SPONSORED ADR / IX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ORIX - SPONSORED ADR (IX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IX.


Can you provide the valuation status for ORIX - SPONSORED ADR?

ChartMill assigns a valuation rating of 4 / 10 to ORIX - SPONSORED ADR (IX). This can be considered as Fairly Valued.


Can you provide the profitability details for ORIX - SPONSORED ADR?

ORIX - SPONSORED ADR (IX) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for IX stock?

The Price/Earnings (PE) ratio for ORIX - SPONSORED ADR (IX) is 19.84 and the Price/Book (PB) ratio is 1.15.


How sustainable is the dividend of ORIX - SPONSORED ADR (IX) stock?

The dividend rating of ORIX - SPONSORED ADR (IX) is 7 / 10 and the dividend payout ratio is 31.18%.